Related Experiment Video

Updated: May 4, 2026

Reinstatement of Drug-seeking in Mice Using the Conditioned Place Preference Paradigm
08:29

Reinstatement of Drug-seeking in Mice Using the Conditioned Place Preference Paradigm

Published on: June 7, 2018

10.8K

Sexual abuse and injury during incarceration reveal the need for re-entry trauma screening

Elizabeth Ford1, Semmie Kim1, Homer Venters1

  • 1Correctional Health Services, New York, NY 10041, USA.

Lancet (London, England)
|April 14, 2017
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Assessment of Nerve Injury-Induced Mechanical Hypersensitivity in Rats Using an Orofacial Operant Pain Assay
07:39

Assessment of Nerve Injury-Induced Mechanical Hypersensitivity in Rats Using an Orofacial Operant Pain Assay

Published on: July 26, 2022

4.4K
Assessing Dominant-Submissive Behavior in Adult Rats Following Traumatic Brain Injury
03:56

Assessing Dominant-Submissive Behavior in Adult Rats Following Traumatic Brain Injury

Published on: December 16, 2022

1.7K

Related Experiment Videos

Last Updated: May 4, 2026

Reinstatement of Drug-seeking in Mice Using the Conditioned Place Preference Paradigm
08:29

Reinstatement of Drug-seeking in Mice Using the Conditioned Place Preference Paradigm

Published on: June 7, 2018

10.8K
Assessment of Nerve Injury-Induced Mechanical Hypersensitivity in Rats Using an Orofacial Operant Pain Assay
07:39

Assessment of Nerve Injury-Induced Mechanical Hypersensitivity in Rats Using an Orofacial Operant Pain Assay

Published on: July 26, 2022

4.4K
Assessing Dominant-Submissive Behavior in Adult Rats Following Traumatic Brain Injury
03:56

Assessing Dominant-Submissive Behavior in Adult Rats Following Traumatic Brain Injury

Published on: December 16, 2022

1.7K

Related Concept Videos

The Stanford Prison Experiment03:20

The Stanford Prison Experiment

22.4K
The famous and controversial Stanford Prison Experiment, conducted by social psychologist Philip Zimbardo and his colleagues at Stanford University, demonstrated the power of social roles, social norms, and scripts.
22.4K

Articles linked to this work by shared authors, journal, and citation graph.

Correction: Local adaptation and validation of a transdiagnostic risk calculator for first episode psychosis using mental health patient records.

Frontiers in psychiatry·2026

Arthroscopic Hip Capsule Closure Augmented With a Nonwoven Polyethylene Terephthalate Scaffolding.

Arthroscopy techniques·2026

Emergency Psychiatric Evaluation of People Under Arrest: Recommendations From a Participatory Policymaking Symposium.

Psychiatric services (Washington, D.C.)·2026

Developing, designing and evaluating co-produced, evidence-based patient resources for adults with blunt chest injuries.

Disability and rehabilitation·2026

Identifying the determinants of hospital readmission in dementia patients - A retrospective cohort study using electronic healthcare records in England.

PloS one·2026

Sussex Integrated Dataset (SID) Data Resource Profile.

International journal of population data science·2026

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

Does Familial Domestic Abuse Present Differently to Intimate Partner Violence? An Exploratory Analysis of Police Data Examining Parent-, Child-, and Sibling-Perpetrated Domestic Abuse.

Behavioral sciences (Basel, Switzerland)·2026

Dark Empaths and Intimate Partner Violence: A Latent Profile Analysis of Dark Tetrad Traits and Empathy Dimensions in Face-to-Face and Cyber Violence Perpetration.

Behavioral sciences (Basel, Switzerland)·2026

Childhood Physical Abuse Perpetrators: Australian National Survey Data on Prevalence and Perpetrator Types.

Child maltreatment·2026

Outpatient Nasal Bone Fractures: An Under-Recognized Marker for Domestic Violence.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026

Is hostility toward women a substantiated risk factor for sexual recidivism? A meta-analysis.

Law and human behavior·2026

Bystander Responses to Street Harassment Based on Gender, Gender Identity and Sexual Orientation: A Qualitative Vignette Study From the United Kingdom.

Journal of interpersonal violence·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us